electroCore (ECOR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.85, -5.99% vs the prior close of $8.35.
- Volume 141.38K shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ECOR slides 6.0% to $7.85, a 1-month low. Closed at $7.85, -5.99% vs the prior close of $8.35. Day range $7.35–$8.42, opened at $8.29.
ECOR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ECOR slides 6.0% to $7.85, a 1-month low
- Closed at $7.85, -5.99% vs the prior close of $8.35. Day range $7.35–$8.42, opened at $8.29.
- Volume was 141.38K shares, 1.6x its 50-day average of 90.11K.
- Price is -20.8% vs its 50-day average ($9.91) and +3.0% vs its 200-day average ($7.62).
- 52-week range $4.41–$12.70; today's close sits at 41% of that range, 38.2% below the 52-week high.
Oct 15, 2026 — ECOR rises 1.8% to $8.35
- Closed at $8.35, +1.83% vs the prior close of $8.20. Day range $7.87–$8.50, opened at $8.13.
- Volume was 93.40K shares, 1.1x its 50-day average of 88.76K.
- Price is -15.6% vs its 50-day average ($9.89) and +9.8% vs its 200-day average ($7.61).
- 52-week range $4.41–$12.70; today's close sits at 48% of that range, 34.3% below the 52-week high.
Oct 14, 2026 — ECOR dips 2.3% to $8.20, a 1-month low, 3 down days in a row
- Closed at $8.20, -2.26% vs the prior close of $8.39. Day range $8.02–$8.57, opened at $8.26.
- Volume was 118.70K shares, 1.3x its 50-day average of 90.35K.
- Price is -16.8% vs its 50-day average ($9.85) and +8.0% vs its 200-day average ($7.59).
- 52-week range $4.41–$12.70; today's close sits at 46% of that range, 35.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ECOR slides 9.6% to $8.39, a 1-month low on 2.1x normal volume
- Closed at $8.39, -9.59% vs the prior close of $9.28. Day range $8.15–$9.39, opened at $9.12.
- Volume was 184.70K shares, 2.1x its 50-day average of 89.53K — unusually heavy trading.
- Price is -14.5% vs its 50-day average ($9.81) and +10.8% vs its 200-day average ($7.57).
- 52-week range $4.41–$12.70; today's close sits at 48% of that range, 33.9% below the 52-week high.
Oct 12, 2026 — ECOR slides 3.9% to $9.28, a 1-month low
- Closed at $9.28, -3.93% vs the prior close of $9.66. Day range $8.97–$9.78, opened at $9.78.
- Volume was 55.30K shares, 0.6x its 50-day average of 89.17K.
- Price is -5.0% vs its 50-day average ($9.77) and +22.8% vs its 200-day average ($7.56).
- 52-week range $4.41–$12.70; today's close sits at 59% of that range, 26.9% below the 52-week high.
Oct 9, 2026 — ECOR rises 1.6% to $9.66
- Closed at $9.66, +1.58% vs the prior close of $9.51. Day range $9.37–$9.79, opened at $9.37.
- Volume was 44.60K shares, 0.5x its 50-day average of 89.47K — lighter than usual.
- Price is -0.4% vs its 50-day average ($9.70) and +28.2% vs its 200-day average ($7.53).
- 52-week range $4.41–$12.70; today's close sits at 63% of that range, 23.9% below the 52-week high.
Oct 8, 2026 — ECOR dips 2.2% to $9.51, 12 down days in a row
- Closed at $9.51, -2.16% vs the prior close of $9.72. Day range $9.42–$10.05, opened at $9.65.
- Volume was 52.90K shares, 0.6x its 50-day average of 89.53K — lighter than usual.
- Price is -1.3% vs its 50-day average ($9.64) and +26.6% vs its 200-day average ($7.51).
- 52-week range $4.41–$12.70; today's close sits at 62% of that range, 25.1% below the 52-week high.
- That makes 12 straight losses.
Oct 7, 2026 — ECOR dips 2.0% to $9.72, 11 down days in a row
- Closed at $9.72, -2.02% vs the prior close of $9.92. Day range $9.69–$10.23, opened at $9.82.
- Volume was 48.60K shares, 0.5x its 50-day average of 89.06K — lighter than usual.
- Price is +1.6% vs its 50-day average ($9.57) and +29.9% vs its 200-day average ($7.49).
- 52-week range $4.41–$12.70; today's close sits at 64% of that range, 23.5% below the 52-week high.
- That makes 11 straight losses.
Oct 6, 2026 — ECOR dips 2.1% to $9.92, 10 down days in a row
- Closed at $9.92, -2.07% vs the prior close of $10.13. Day range $9.89–$10.45, opened at $10.25.
- Volume was 39.40K shares, 0.4x its 50-day average of 88.90K — lighter than usual.
- Price is +4.5% vs its 50-day average ($9.49) and +33.0% vs its 200-day average ($7.46).
- 52-week range $4.41–$12.70; today's close sits at 66% of that range, 21.9% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — ECOR ends flat (-0.1%) to $10.13, 9 down days in a row
- Closed at $10.13, -0.10% vs the prior close of $10.14. Day range $9.90–$10.25, opened at $10.14.
- Volume was 32.00K shares, 0.4x its 50-day average of 88.87K — lighter than usual.
- Price is +7.6% vs its 50-day average ($9.42) and +36.3% vs its 200-day average ($7.43).
- 52-week range $4.41–$12.70; today's close sits at 69% of that range, 20.2% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — ECOR dips 1.7% to $10.14, 8 down days in a row
- Closed at $10.14, -1.70% vs the prior close of $10.31. Day range $9.92–$11.02, opened at $10.47.
- Volume was 122.20K shares, 1.4x its 50-day average of 87.23K.
- Price is +8.6% vs its 50-day average ($9.34) and +36.9% vs its 200-day average ($7.41).
- 52-week range $4.41–$12.70; today's close sits at 69% of that range, 20.2% below the 52-week high.
- That makes 8 straight losses.
ECOR latest news & SEC filings
Every SEC filing by or about ECOR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Errico Thomas J. bought 5,000 shares at $9.82 (≈$49.08K) on Sep 14, 2026; now holds 363,904
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Fox Michael bought 5,000 shares at $9.80 (≈$49.00K) on Sep 11, 2026; now holds 130,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $9.45M (prior year $7.38M) (+28.0% vs Jun 30, 2025)
- Net income: -$3.06M (prior year -$3.67M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.33 (prior year -$0.44) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade ECOR
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 19, 2026, Jan 20, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.77% (largest 9.6%).
- Liquidity: about 86.91K shares (≈$682.24K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.85 vs a range of $4.41–$12.70 (41% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 13 sales; latest: Thomas J. Errico bought 5,000 shares on Sep 14, 2026.
- Latest filings: 8-K Sep 9, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 9.02M shares outstanding (Jul 31, 2026), +18.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
ECOR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.29 | 8.42 | 7.35 | 7.85 | 141.38K |
| Oct 15, 2026 | 8.13 | 8.50 | 7.87 | 8.35 | 93.40K |
| Oct 14, 2026 | 8.26 | 8.57 | 8.02 | 8.20 | 118.70K |
| Oct 13, 2026 | 9.12 | 9.39 | 8.15 | 8.39 | 184.70K |
| Oct 12, 2026 | 9.78 | 9.78 | 8.97 | 9.28 | 55.30K |
| Oct 9, 2026 | 9.37 | 9.79 | 9.37 | 9.66 | 44.60K |
| Oct 8, 2026 | 9.65 | 10.05 | 9.42 | 9.51 | 52.90K |
| Oct 7, 2026 | 9.82 | 10.23 | 9.69 | 9.72 | 48.60K |
| Oct 6, 2026 | 10.25 | 10.45 | 9.89 | 9.92 | 39.40K |
| Oct 5, 2026 | 10.14 | 10.25 | 9.90 | 10.13 | 32.00K |
| Oct 2, 2026 | 10.47 | 11.02 | 9.92 | 10.14 | 122.20K |
| Oct 1, 2026 | 11.00 | 11.08 | 10.00 | 10.31 | 97.50K |
| Sep 30, 2026 | 10.73 | 11.09 | 10.65 | 10.82 | 49.20K |
| Sep 29, 2026 | 11.16 | 11.33 | 10.52 | 10.88 | 63.30K |
| Sep 28, 2026 | 11.00 | 11.28 | 10.73 | 11.03 | 114.30K |
| Sep 25, 2026 | 11.34 | 11.47 | 11.00 | 11.12 | 52.20K |
| Sep 24, 2026 | 11.43 | 11.74 | 11.18 | 11.35 | 68.90K |
| Sep 23, 2026 | 12.04 | 12.13 | 11.25 | 11.42 | 113.30K |
| Sep 22, 2026 | 12.18 | 12.70 | 11.99 | 12.29 | 126.20K |
| Sep 21, 2026 | 11.74 | 12.12 | 11.35 | 11.99 | 120.10K |
About electroCore
electroCore (ECOR) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in ROCKAWAY, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1560258.
ECOR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Elena Bonfiglioli | Director | Sep 10, 2026 |
| Thomas J. Errico | Director | Sep 22, 2026 |
| John P Gandolfo | Director | Sep 10, 2026 |
| Julie Ann Goldstein | Director | Sep 10, 2026 |
| James Charles Theofilos | Director | Sep 10, 2026 |
| Patricia Wilber | Director | Sep 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Fox | See Remarks | Sep 18, 2026 |
| Joshua S. Lev | See Remarks | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Thomas J. Errico | Buy | 5,000 | $9.82 |
| Sep 14, 2026 | Thomas J. Errico | Buy | 5,000 | $9.82 |
| Sep 14, 2026 | Thomas J. Errico | Buy | 5,000 | $9.82 |
| Sep 14, 2026 | Thomas J. Errico | Buy | 5,000 | $9.82 |
| Sep 11, 2026 | Michael Fox | Buy | 5,000 | $9.80 |
| Sep 11, 2026 | Michael Fox | Buy | 5,000 | $9.80 |
| Sep 11, 2026 | Michael Fox | Buy | 5,000 | $9.80 |
| Sep 11, 2026 | Michael Fox | Buy | 5,000 | $9.80 |
| Aug 25, 2026 | Joshua S. Lev | Sale | 3,000 | $9.36 |
| Aug 25, 2026 | Joshua S. Lev | Sale | 3,000 | $9.36 |
| Aug 25, 2026 | Joshua S. Lev | Sale | 3,000 | $9.36 |
| Aug 25, 2026 | Joshua S. Lev | Sale | 3,000 | $9.36 |
| Aug 24, 2026 | Joshua S. Lev | Sale | 5,000 | $9.88 |
| Aug 24, 2026 | Joshua S. Lev | Sale | 5,000 | $9.88 |
| Aug 24, 2026 | Joshua S. Lev | Sale | 5,000 | $9.88 |
ECOR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $32.03M | $-13.97M | -1.65 | $-8.19M |
| Dec 31, 2024 | $25.18M | $-11.89M | -1.59 | $-6.95M |
| Dec 31, 2023 | $16.03M | $-18.83M | -3.42 | $-14.67M |
| Dec 31, 2022 | $8.59M | $-22.16M | -4.69 | $-16.64M |
| Dec 31, 2021 | $5.45M | $-17.22M | -4.36 | $-13.63M |
Latest balance sheet: total assets $17.06M, total liabilities $19.85M, cash $8.50M (as of Jun 30, 2026).
ECOR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $6.70 |
| May 6, 2026 | 8-K Item 2.02 (results) | $6.66 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $6.55 |
| Jan 20, 2026 | 8-K Item 2.02 (results) | $6.88 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $4.74 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $6.93 |
| May 7, 2025 | 8-K Item 2.02 (results) | $6.81 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $13.00 |
| Jan 17, 2025 | 8-K Item 2.02 (results) | $15.90 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $13.40 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ECOR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.